This topic contains a solution. Click here to go to the answer

Author Question: What is unusual about olfactory receptors compared to most other mature mammalian neurons? a. ... (Read 90 times)

audragclark

  • Hero Member
  • *****
  • Posts: 579
What is unusual about olfactory receptors compared to most other mature mammalian neurons?
 
  a. They have more than one axon each.
 b. They have no axons.
 c. They are replaceable when old neurons die.
  d. They use more than one neurotransmitter.

Question 2

In contrast to tricyclics, selective serotonin reuptake inhibitors (SSRIs) ____.
 
  a. block reuptake of both catecholamines and serotonin
 b. increase action potential velocity
 c. block the reuptake of only serotonin
 d. act on the left hemisphere while tricyclics act on the right



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

SVictor

  • Sr. Member
  • ****
  • Posts: 365
Answer to Question 1

c

Answer to Question 2

c





 

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Pink eye is a term that refers to conjunctivitis, which is inflammation of the thin, clear membrane (conjunctiva) over the white part of the eye (sclera). It may be triggered by a virus, bacteria, or foreign body in the eye. Antibiotic eye drops alleviate bacterial conjunctivitis, and antihistamine allergy pills or eye drops help control allergic conjunctivitis symptoms.

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

Illness; diuretics; laxative abuse; hot weather; exercise; sweating; caffeine; alcoholic beverages; starvation diets; inadequate carbohydrate consumption; and diets high in protein, salt, or fiber can cause people to become dehydrated.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library